Trial Profile

A Phase 2b, Open-label Long-term Durability Study of CCH Following Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Collagenase clostridium histolyticum (Primary)
Indications Cellulite
Focus Therapeutic Use
Sponsors Endo Pharmaceuticals

Most Recent Events

09 Oct 2020 According to an Endo International media release, data from this study will be featured as an oral presentation during the American Society for Dermatologic Surgerys Annual Meeting (ASDS; virtual meeting taking place on 9th to 11th Oct 2020.).
04 Aug 2020 Status changed from recruiting to completed.
12 May 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com